The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
DENALI THERAPEUTICS INC | COM | 24823R105 | 451,919 | 19,462,500 | SH | SOLE | 19,462,500 | 0 | 0 | ||
MONGODB INC | CL A | 60937P106 | 2,029 | 13,800 | SH | SOLE | 13,800 | 0 | 0 | ||
SPDR GOLD TRUST | GOLD SHS | 78463V107 | 7,156 | 58,650 | SH | SOLE | 58,650 | 0 | 0 |